MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Clinical trials for MULTIPLE SCLEROSIS, RELAPSING-REMITTING explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS, RELAPSING-REMITTING trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS, RELAPSING-REMITTING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
MS treatment showdown: does early aggressive therapy prevent disability better?
Disease control OngoingThis study compares two approaches for treating relapsing-remitting multiple sclerosis: starting with strong medications early versus beginning with milder drugs and switching if needed. Researchers want to see which strategy better prevents long-term disability. About 900 adults…
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated May 26, 2026 09:39 UTC
-
New study tracks Kesimpta's Real-World impact on MS relapses
Disease control OngoingThis study looks at how well the drug ofatumumab (Kesimpta®) works for people with relapsing-remitting multiple sclerosis (RRMS) in everyday medical practice in Italy. About 379 adults who are already starting the drug will be followed for 12 months to see how many relapses they …
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 09:34 UTC
-
New pill aims to stop MS Flare-Ups in their tracks
Disease control OngoingThis study tests an oral medication called IMU-838 against a placebo in about 1,100 adults with relapsing multiple sclerosis (MS). The goal is to see if the drug can reduce the number of relapses (flare-ups) and limit new brain damage seen on MRI scans. Participants take the pill…
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Phase: PHASE3 • Sponsor: Immunic AG • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
MS patients switch meds – will it work as well?
Disease control OngoingThis study looks at 184 people with relapsing-remitting multiple sclerosis who switched from the drug MabThera to a similar drug called Rixathon. Researchers want to see if the switch changes nerve damage, brain lesions, relapses, or disability. They will use existing medical rec…
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Sponsor: Uppsala University • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
New hope for kids with MS: drug trial aims to cut relapses
Disease control OngoingThis study tests an experimental drug called BIIB017 in children aged 10 to 17 with relapsing-remitting multiple sclerosis (MS). The goal is to see if the drug can reduce the number of MS attacks (relapses) and is safe for long-term use. Participants will receive either BIIB017 o…
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Diet showdown: could keto or paleo ease MS symptoms?
Symptom relief OngoingThis study looks at whether following a special diet (either a time-restricted keto diet with olive oil or a modified Paleo diet) can improve quality of life for people with relapsing-remitting multiple sclerosis compared to standard dietary guidelines. About 162 participants wil…
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Phase: NA • Sponsor: Terry L. Wahls • Aim: Symptom relief
Last updated Apr 26, 2026 20:00 UTC
-
Hidden survivors: MS drug may miss key immune cells in lymph nodes
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how well the MS medication ocrelizumab removes B cells from lymph nodes, not just from blood. Researchers will analyze lymph node samples from 5 people with relapsing-remitting MS who are starting ocrelizumab. The goal is to understand why some immune cells re…
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 26, 2026 09:37 UTC
-
Could a breathing trick plus mild zaps rewire the brain in MS?
Knowledge-focused OngoingThis study looks at whether pairing brief, low-oxygen breathing (AIH) with electrical muscle stimulation (NMES) can boost brain-to-muscle signals in people with relapsing forms of multiple sclerosis. Forty participants will have their ankle strength and brain responses measured a…
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Phase: NA • Sponsor: Shirley Ryan AbilityLab • Aim: Knowledge-focused
Last updated May 26, 2026 09:26 UTC